Titan Pharmaceuticals logo
Titan Pharmaceuticals TTNP
$ 3.35 2.45%

Quarterly report 2024-Q2
added 08-15-2024

report update icon

Titan Pharmaceuticals EV/EBITDA Ratio 2011-2024 | TTNP

Annual EV/EBITDA Ratio Titan Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.717 -0.762 -0.301 -1.19 -1.97 14.8 -9.83 -9.53 -60.7 -14 -7.42

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
14.8 -60.7 -8.32